![Michael Engsig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Engsig
Directeur Général chez
NYKODE THERAPEUTICS
Fortune : 24 371 $ au 31/05/2026
Profil
Michael Thyrring Engsig currently works at Nykode Therapeutics ASA, as Chief Executive Officer from 2019 and FluoGuide A, as Independent Director from 2023.
Mr. Engsig also formerly worked at Takeda A, as Director-Research & Development and KLIFO A, as EVP-Drug Development Counselling.
Mr. Engsig received his graduate degree from Technical University of Denmark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/10/2025 | 71 794 ( 0,02% ) | 24 371 $ | 31/05/2026 |
Postes actifs de Michael Engsig
| Sociétés | Poste | Début |
|---|---|---|
| NYKODE THERAPEUTICS | Directeur Général | 01/01/2019 |
| FLUOGUIDE A/S | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Michael Engsig
| Sociétés | Poste | Fin |
|---|---|---|
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | - |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Directeur Technique/Scientifique/R&D | - |
Formation de Michael Engsig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
FluoGuide A/S
 FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
